Treatment patterns in COPD patients newly diagnosed in primary care: a population-based study. Respir Med. 2016;111:47-53.Barrecheguren M, Monteagudo M, Ferrer J, Borrell E, Llor C, Esquinas C, et al. Treatment patterns in COPD patients newly diagnosed in primary care. A population-...
In this article, Drs Cote and Celli discuss the latest developments in treatment of COPD and outline an approach to pharmacologic therapy and overall management that can improve the quality and length of life for patients with this disease.
The drug, marketed as Bevespi Aerosphere, is indicated for long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) (http://1.usa.gov/1qVyi94). Glycopyrrolate is a long-acting muscarinic antagonist (LAMA) while formoterol fumarate is ...
How long does the Stem Cell Treatment for COPD effect last? While results can vary, many patients experience benefits for several years after the treatment. Is the treatment painful? The procedure is generally not painful, with most discomfort coming from the initial injection, which is often man...
European Respiratory Society 2005 These slides can be used freely for non-commercial purposes. Document authors Document Goals and Objectives (1) The Standards for the Diagnosis and Treatment of Patients with COPD document updates the position papers on COPD published by the ATS and the ERS in ...
Bronchodilators are the first-line therapy for all patients. With COPD disease progression, combination therapy is often required to control the symptoms, which include 2 bronchodilators, such as a long-acting beta-2 agonist (LABA), plus a long-acting muscarinic antagonist (LAMA). This therapy ...
“This latest FDA approval for (dupilumab) represents new hope for the hundreds of thousands of COPD patients in the U.S. who can sometimes struggle just to breathe during their everyday lives,” George D. Yancopoulos, MD, PhD, president and chief scientific officer at Regeneron, and princip...
Chronic Obstructive Pulmonary Disease (COPD) is used to describe group of progressive lung diseases, including emphysema, chronic bronchitis, refractory asthma. Know more about COPD, its causes, symptoms, treatment and videos on Health-Wiki | Practo
Learn about DALIRESP for patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
Factors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a cross-sectional study To identify the differential effects of patient, health service, temporal and geographic factors on length of stay (LOS) for chronic obstructive pulmonary ... G Agboado,...